LDLR and familial hyperaldosteronism: Variants in APOB are present in approximately 5% to 10% of individuals with a clinical diagnosis of heterozygous FH.1 The APOB variants lead to a defective apolipoprotein B100, a crucial ligand for LDLR, and often induce a milder phenotype when compared to LDLR variants.